SL
MEDP icon

Salomon & Ludwin’s Medpace MEDP Stock Holding History

Salomon & Ludwin’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.07K Hold
13
– – ﹤0.01% 1723
2026
Q1 		$6.48K Hold
13
– – ﹤0.01% 1685
2025
Q4 		$7.63K Hold
13
– – ﹤0.01% 1596
2025
Q3 		$6.92K Buy
+13
New +$5.68K ﹤0.01% 1561

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Salomon & Ludwin's MEDP Position: Q2 2026 in Review

Salomon & Ludwin held its Medpace (MEDP) position steady in Q2 2026 at 13 shares worth $7.07K. The position accounts for ﹤0.01% of the portfolio, ranked #1723.

Salomon & Ludwin first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.63K in Q4 2025. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Salomon & Ludwin held 13 shares of Medpace worth $7.07K as of Q2 2026.
  • Salomon & Ludwin left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1723 holding.
  • Salomon & Ludwin first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • Salomon & Ludwin's Medpace position peaked at $7.63K in Q4 2025.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.